Olsson M L, Thuresson B, Chester M A
Blood Centre, University Hospital, Lund, Sweden.
Biochem Biophys Res Commun. 1995 Nov 13;216(2):642-7. doi: 10.1006/bbrc.1995.2670.
Genomic DNA from each of four Acl individuals (genotypes AO1, AO1var, AO2) and one AclB individual was used as a template for amplifying exons 6 and 7 of the ABO genes, which were subsequently sequenced. In all the Ael alleles a single nucleotide insertion, compared to the A consensus sequence, was observed that would alter the amino acid sequence of the glycosyltransferase immediately after its postulated nucleotide sugar binding site and furthermore extend the translated protein by 37 amino acids (16 more than the A2 enzyme). A sequence-specific primer PCR assay was developed to detect the nucleotide insertion. It was possible to differentiate all 20 serologically defined Acl/AclB individuals available from 145 blood donors with normal ABO phenotypes and genotypes and 26 individuals with various A subgroups other than A1, A2 and Acl. This mutation explains the Acl phenotype and forms the basis of a method for detecting the Ael allele.
从四个Ael个体(基因型AO1、AO1var、AO2)和一个AelB个体中提取的基因组DNA用作模板,用于扩增ABO基因的外显子6和7,随后对其进行测序。在所有Ael等位基因中,与A一致序列相比,观察到一个单核苷酸插入,该插入会在假定的核苷酸糖结合位点之后立即改变糖基转移酶的氨基酸序列,并进一步使翻译后的蛋白质延长37个氨基酸(比A2酶多16个)。开发了一种序列特异性引物PCR检测方法来检测核苷酸插入。能够区分来自145名具有正常ABO表型和基因型的献血者以及26名具有除A1、A2和Ael之外的各种A亚组的个体中所有20个血清学定义的Ael/AelB个体。这种突变解释了Ael表型,并构成了检测Ael等位基因方法的基础。